| Literature DB >> 31516874 |
Abstract
OBJECTIVES: Despite advancements in the management of oral cancer, the mortality rate associated with it still remains a matter of concern. Early identification and intervention of precursor lesions such as leukoplakia have always been emphasized, as this can drastically improve the scenario. The oxidative stress has been implicated in the pathogenesis of several diseases, including oral cancer. The aim of this study was to evaluate salivary oxidant and antioxidant levels in patients with different clinicopathological stages of oral leukoplakia.Entities:
Keywords: Free radicals; glutathione S-transferase; oral leukoplakia
Year: 2019 PMID: 31516874 PMCID: PMC6714417 DOI: 10.4103/jispcd.JISPCD_179_19
Source DB: PubMed Journal: J Int Soc Prev Community Dent ISSN: 2231-0762
Descriptive analysis for sample size and variables related to biographic data, tobacco habit, site of lesion, and clinical staging and histopathological grading in different study groups
| S. No. | Variable | Study group | Frequency | Total | |||
|---|---|---|---|---|---|---|---|
| 1 | Sample size ( | Group A (control) | 40 | 80 | |||
| variables related to biographic date | |||||||
| 2 | Age, expressed as mean ± SD | Group A | 39.55 ± 9.106 | ||||
| 3 | Gender, expressed as number (%) | Responses | |||||
| Male | Female | ||||||
| Group A | 30 (75) | 10 (25) | |||||
| Group B | 30 (75) | 10 (25) | |||||
| Variables related to tobacco habit | |||||||
| 4 | Duration of habit (years), expressed as mean ± SD | Group B | 20.80 ± 10.469 | ||||
| 5 | Frequency of habit (no. of times/day), expressed as mean ± SD | Group B | 7.85 ± 3.317 | ||||
| Variables related to site of lesion | |||||||
| 6 | Site of lesion, expressed as number (%) | Group B | Responses | ||||
| Buccal mucosa | Alveolus | Vestibule | Tongue | ||||
| 30 (75) | 2 (5) | 4 (10) | 4 (10) | ||||
| Variables related to clinical stages and histopathological grades of group B—leukoplakia | |||||||
| 7 | Clinical staging (OLEP stages), expressed as number (%) | Group B | Responses | ||||
| Stage I | Stage II | Stage II | Stage III | Stage IV | |||
| 8 | Histopathological grading—dysplasia, expressed as number (%) | Group B | Responses | ||||
| Mild | Moderate | Severe | |||||
| 10 (25) | 14 (35) | 16 (40) | |||||
OLEP = oral leukoplakia, SD = standard deviation
Intergroup comparative analysis of salivary parameters related to lipid peroxidation and antioxidant enzymes
| S. No. | Variable | Study group A (mean ± SD) | Study group B (mean ± SD) | |
|---|---|---|---|---|
| 1 | TBARS | 3.398 ± 0.017 | 3.760 ± 0.012 | 0.000‡ |
| 2 | Nitrates | 74.950 ± 7.702 | 174 ± 8.834 | 0.000‡ |
| 3 | GST | 226.850 ± 4.520 | 187.150 ± 4.709 | 0.000‡ |
| 4 | Uric acid | 3.667 ± 0.355 | 2.174 ± 0.261 | 0.000‡ |
Independent Student’s t test (test of significance) is applied at 95% confidence interval. TBARS = thiobarbituric acid reactive substances, GST = glutathione S-transferase, SD = standard deviation ‡P value < 0.001.
Comparative analysis of salivary parameters related to lipid peroxidation and antioxidant enzymes within clinical stages (OLEP stages) of study group B
| S. No | Variable | Study group B—clinical stages | ||||
|---|---|---|---|---|---|---|
| Stage I (Mean ± SD) | Stage II (Mean ± SD) | Stage III (Mean ± SD) | Stage IV (Mean ± SD) | |||
| 1 | TBARS | 3.747 ± 0.004 b†c‡d‡ | 3.755 ± 0.002 a†c*d‡ | 3.761 ± 0.006 a‡b*d‡ | 3.786 ± 0.004 a‡b‡c‡ | |
| 2 | Nitrates | 162.250 ± 0.886 b‡c‡d‡ | 170.143 ± 2.315 a‡c‡d‡ | 179 ± 2.256 a‡b‡d‡ | 188.667 ± 1.366 a‡b‡c‡ | |
| 3 | GST | 194.250 ± 0.886 b‡c‡d‡ | 188.714 ± 1.069 a‡c‡d‡ | 184 ± 0.852 a‡b‡d‡ | 180.333 ± 0.5164 a‡b‡c‡ | |
| 4 | Uric acid | 2.570 ± 0.103 b‡c‡d‡ | 2.221 ± 0.140 a‡c‡d‡ | 2.031 ± 0.060 a‡b‡d† | 1.823 ± 0.080 a‡b‡c† | |
One-way ANOVA with post hoc Tukey test (test of significance) is applied at 95% confidence interval. a = compared to stage I, b = compared to stage II, c = compared to stage III, d = compared to stage IV, TBARS = thiobarbituric acid reactive substances, GST = glutathione S-transferase, SD = standard deviation *P value < 0.05; †P value < 0.01; ‡P value < 0.001.
Comparative analysis of salivary parameters related to lipid peroxidation and antioxidant enzymes within histopathological grades of study group B
| S. No. | Variable | Study group B—histopathological grades | |||
|---|---|---|---|---|---|
| Mild dysplasia (mean ± SD) | Moderate dysplasia (mean ± SD) | Severe dysplasia (mean ± SD) | |||
| 1 | TBARS | 3.749 ± 0.005 c‡ | 3.755 ± 0.004 c† | 3.769 ± 0.014 a‡b† | 0.000‡ |
| 2 | Nitrates | 163.800 ± 3.359 b†c‡ | 171.571 ± 4.255 a†c‡ | 182.500 ± 5.341 a‡b‡ | 0.000‡ |
| 3 | GST | 193.400 ± 1.955 b‡c‡ | 187.857 ± 1.875 a‡c‡ | 182.625 ± 1.995 a‡b‡ | 0.000‡ |
| 4 | Uric acid | 2.512 ± 0.152 b‡c‡ | 2.198 ± 0.141 a‡c‡ | 1.942 ± 0.112 a‡b‡ | 0.000‡ |
One-way ANOVA with post hoc Tukey test (test of significance) is applied at 95% confidence interval. a = compared to mild dysplasia; b = compared to moderate dysplasia; c = compared to severe dysplasia, TBARS = thiobarbituric acid reactive substances, GST = glutathione S-transferase, SD = standard deviation †P value < 0.01; ‡P value < 0.001.
Correlation analysis of salivary parameters with variables related to habit, biographic, clinical stages, and histopathological grades
| S. N. | Variable | Salivary parameters | Habit related | Biographic related | Clinical and histopathology related | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TBARS | Nitrates | GST | Uric acid | Duration of habit | Frequency of habit | Age | Gender | Site | Clinical stage | HP grade | ||
| 1 | TBARS | — | 0.000‡ (0.848) | 0.000‡ (−0.812) | 0.000‡ (−0.719) | 0.089 (−0.273) | 0.024* (0.357) | 0.307 (−0.166) | 0.010* (0.401) | 0.104 (0.261) | 0.000‡ (0.848) | 0.000‡ (0.709) |
| 2 | Nitrates | 0.000‡ (0.848) | — | 0.000‡ (−0.96) | 0.000‡ (−0.87) | 0.287 (−0.172) | 0.042* (0.324) | 0.672 (−0.069) | 0.008† (0.411) | 0.727 (0.057) | 0.000‡ (0.961) | 0.000‡ (0.864) |
| 3 | GST | 0.000‡ (−0.812) | 0.000‡ (−0.966) | — | 0.000‡ (0.909) | 0.516 (0.106) | 0.054 (−0.307) | 0.905 (−0.019) | 0.007† (−0.422) | 0.528 (−0.103) | 0.000‡ (−0.963) | 0.000‡ (−0.906) |
| 4 | Uric acid | 0.000‡ (−0.719) | 0.000‡ (−0.878) | 0.000‡ (0.909) | — | 0.810 (−0.039) | 0.012* (−0.392) | 0.560 (−0.095) | 0.044* (−0.321) | 0.776 (0.047) | 0.000‡ (−0.899) | 0.000‡ (−0.859) |
Pearson and spearman correlation is applied at 95% confidence interval for quantitative (TBARS, nitrates, GST, uric acid, duration of habit, frequency of habit, and age) and qualitative (gender, site, clinical stages, and histopathological grades), respectively. TBARS = thiobarbituric acid reactive substances, GST = glutathione S-transferase, HP = histopathological *P value < 0.05; †P value < 0.01; ‡P value < 0.001.